| Record Information |
|---|
| Version | 1.0 |
|---|
| Creation Date | 2016-05-22 05:29:04 UTC |
|---|
| Update Date | 2016-11-09 01:15:51 UTC |
|---|
| Accession Number | CHEM018726 |
|---|
| Identification |
|---|
| Common Name | Devazepide |
|---|
| Class | Small Molecule |
|---|
| Description | An indolecarboxamide obtained by formal condensation of the carboxy group of indole-2-carboxylic acid with the exocyclic amino group of (3S)-3-amino-1-methyl-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one. A cholecystokinin antagonist used for treatment of gastrointestinal disorders. |
|---|
| Contaminant Sources | - ToxCast & Tox21 Chemicals
|
|---|
| Contaminant Type | Not Available |
|---|
| Chemical Structure | |
|---|
| Synonyms | | Value | Source |
|---|
| (S)-N-(2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)indole-2-carboxamide | ChEBI | | 3(S)-(-)-1,3-Dihydro-3-(2-indolecarbonylamino)-1-methyl-5-phenyl-2H-(1,4)benzodiazepin-2-one | ChEBI | | Devazepida | ChEBI | | Devazepidum | ChEBI | | L 364718 | ChEBI | | MK-329 | ChEBI |
|
|---|
| Chemical Formula | C25H20N4O2 |
|---|
| Average Molecular Mass | 408.461 g/mol |
|---|
| Monoisotopic Mass | 408.159 g/mol |
|---|
| CAS Registry Number | 103420-77-5 |
|---|
| IUPAC Name | N-[(3R)-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]-1H-indole-2-carboximidic acid |
|---|
| Traditional Name | devazepida |
|---|
| SMILES | [H][C@]1(N=C(O)C2=CC3=CC=CC=C3N2)N=C(C2=CC=CC=C2)C2=CC=CC=C2N(C)C1=O |
|---|
| InChI Identifier | InChI=1S/C25H20N4O2/c1-29-21-14-8-6-12-18(21)22(16-9-3-2-4-10-16)27-23(25(29)31)28-24(30)20-15-17-11-5-7-13-19(17)26-20/h2-15,23,26H,1H3,(H,28,30)/t23-/m1/s1 |
|---|
| InChI Key | NFHRQQKPEBFUJK-HSZRJFAPSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | belongs to the class of organic compounds known as n-acyl-alpha amino acids and derivatives. N-acyl-alpha amino acids and derivatives are compounds containing an alpha amino acid (or a derivative thereof) which bears an acyl group at its terminal nitrogen atom. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Amino acids, peptides, and analogues |
|---|
| Direct Parent | N-acyl-alpha amino acids and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - N-acyl-alpha amino acid or derivatives
- Indolecarboxamide derivative
- Indolecarboxylic acid derivative
- Benzodiazepine
- 1,4-benzodiazepine
- Indole
- Indole or derivatives
- 2-heteroaryl carboxamide
- Pyrrole-2-carboxamide
- Pyrrole-2-carboxylic acid or derivatives
- Monocyclic benzene moiety
- Benzenoid
- Substituted pyrrole
- Heteroaromatic compound
- Tertiary carboxylic acid amide
- Pyrrole
- Ketimine
- Lactam
- Carboxamide group
- Secondary carboxylic acid amide
- Organoheterocyclic compound
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Azacycle
- Hydrocarbon derivative
- Organopnictogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Imine
- Organonitrogen compound
- Carbonyl group
- Organooxygen compound
- Organic oxide
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Biological Properties |
|---|
| Status | Detected and Not Quantified |
|---|
| Origin | Not Available |
|---|
| Cellular Locations | Not Available |
|---|
| Biofluid Locations | Not Available |
|---|
| Tissue Locations | Not Available |
|---|
| Pathways | Not Available |
|---|
| Applications | Not Available |
|---|
| Biological Roles | Not Available |
|---|
| Chemical Roles | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Appearance | Not Available |
|---|
| Experimental Properties | | Property | Value |
|---|
| Melting Point | Not Available | | Boiling Point | Not Available | | Solubility | Not Available |
|
|---|
| Predicted Properties | |
|---|
| Spectra |
|---|
| Spectra | | Spectrum Type | Description | Splash Key | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-08fr-0190300000-991e7172a6d0b9da8306 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-03di-0290000000-f4a466965c51a467b307 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0ar0-1920000000-4a979c6181ab8ba2a2e0 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-0a4i-0330900000-e97febc7034d9dfded40 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-0a4i-0961400000-3a0cf78e42ec2eda6e37 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-07bf-6940000000-e862d5652ad12427b651 | Spectrum |
|
|---|
| Toxicity Profile |
|---|
| Route of Exposure | Not Available |
|---|
| Mechanism of Toxicity | Not Available |
|---|
| Metabolism | Not Available |
|---|
| Toxicity Values | Not Available |
|---|
| Lethal Dose | Not Available |
|---|
| Carcinogenicity (IARC Classification) | Not Available |
|---|
| Uses/Sources | Not Available |
|---|
| Minimum Risk Level | Not Available |
|---|
| Health Effects | Not Available |
|---|
| Symptoms | Not Available |
|---|
| Treatment | Not Available |
|---|
| Concentrations |
|---|
| Not Available |
|---|
| External Links |
|---|
| DrugBank ID | Not Available |
|---|
| HMDB ID | Not Available |
|---|
| FooDB ID | Not Available |
|---|
| Phenol Explorer ID | Not Available |
|---|
| KNApSAcK ID | Not Available |
|---|
| BiGG ID | Not Available |
|---|
| BioCyc ID | Not Available |
|---|
| METLIN ID | Not Available |
|---|
| PDB ID | Not Available |
|---|
| Wikipedia Link | Devazepide |
|---|
| Chemspider ID | Not Available |
|---|
| ChEBI ID | 4460 |
|---|
| PubChem Compound ID | 443375 |
|---|
| Kegg Compound ID | C11710 |
|---|
| YMDB ID | Not Available |
|---|
| ECMDB ID | Not Available |
|---|
| References |
|---|
| Synthesis Reference | Not Available |
|---|
| MSDS | Not Available |
|---|
| General References | |
|---|